Drug Treatment of Sleep Disorders

Covering their prevalence, classification using systems like ICSD-3, and the underlying neurophysiology that governs wakefulness and sleep stages. A significant portion of the text discusses the pharmacological treatment of these disorders, detailing the mechanisms of action for various drug classes, including GABA-receptor modulators (such as benzodiazepines, zolpidem, and Lorediplon), orexin/hypocretin antagonists (like suvorexant and almorexant), and wake-promoting agents (such as modafinil and sodium oxybate). Finally, the sources explore the complex and regulated process of developing new therapeutic agents for sleep disorders, emphasizing clinical trials, safety considerations, and future directions in drug research, including cell replacement therapy for conditions like narcolepsy.Get the Book now from Amazon:https://www.amazon.com/Treatment-Sleep-Disorders-Milestones-Therapy/dp/3319379208?&linkCode=ll1&tag=cvthunderx-20&linkId=00fbc464b8a0a986c6ec8d2b11661a8a&language=en_US&ref_=as_li_ss_tlYou can listen and download our episodes for free on more than 10 different platforms:https://linktr.ee/pharmacy_simpleProduced by:https://www.podcaistudio.com/